Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2021 Earnings Conference Call November 3, 2021 11:30 AM ET Company Participants Jennifer Capuzela - Director of Investor Relation Brett Monia - Founder, CEO & Director Beth Hougen - Chief Financial Officer Richard Geary - EVP & Chief Development Officer Onaiza Cadoret-Manier - EVP and Chief Corporate Development & Commercial Officer Eric Swayze - EVP of Research Conference Call Participants Yale Jen - Laidlaw & Co Chi Meng Fong - BofA Securities Yanan Zhu - Wells ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2021 Earnings Conference Call August 4, 2021 11:30 AM ET Company Participants David Nakasone - IR Brett Monia - Founder, CEO & Director Elizabeth Hougen - EVP, Finance & CFO Richard Geary - EVP & Chief Development Officer Eric Swayze - EVP, Research Onaiza Cadoret-Manier - EVP & Chief Corporate Development & Commercial Officer Conference Call Participants Jason Gerberry - Bank of America Merrill Lynch Luca Issi - RBC Capital Markets Brendan Smith - Cowen and Comp ...

| --- | --- | --- | --- | --- | --- | |------------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2021 Annual Meeting of | | | | | | | Stockholders Corporate | | | | | | | Presentation | | | | | | | June 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Changes to the Ionis Board of Directors (1 of 2) 2 Departures Stanley T. Crooke, M.D., Ph.D. Ionis Founder and Executive Chairman 30 Years of ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2021 Earnings Conference Call May 5, 2021 11:30 AM ET Company Participants Wade Walke - VP, IR Brett Monia - CEO Beth Hougen - CFO Richard Geary - EVP of Development Eric Swayze - EVP of Research Onaiza Cadoret - Chief Corporate Development and Commercial Officer Conference Call Participants Luca Issi - RBC Yaron Werber - Cowen Yanan Zhu - Wells Fargo Yale Jen - Laidlaw and Company Jason Gerberry - Bank of America Jessica Fye - JP Morgan Mani Foroohar - SVB Leeri ...

| --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | On Today's Earnings Call | --- | --- | --- | --- | |--------------------------------------------|--------------------|-------------------------------------|--------------------------------------------------------------------| | | | | | | | | | | | Brett Monia, Ph.D. Chief Executive Officer | | Beth Hougen Chief Financial Officer | Richard Geary, Ph.D. Executive Vice President, De ...

IONIS" FY 2020 Financial Results and Business Update February 24, 2021 On Today's Earnings Call | --- | --- | --- | --- | |--------------------------------------------|--------------------|-------------------------------------|--------------------------------------------------------------------| | | | | | | | | | | | Brett Monia, Ph.D. Chief Executive Officer | | Beth Hougen Chief Financial Officer | Richard Geary, Ph.D. Executive Vice President, Development | | | Eric Swayze, Ph.D. | Executive Vice Preside ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q4 2020 Earnings Conference Call February 24, 2020 9:00 AM ET Company Participants Wade Walke - VP, IR Brett Monia - CEO Beth Hougen - CFO Richard Geary - EVP of Development Onaiza Cadoret - Chief Corporate Development and Commercial Officer Eric Swayze - EVP of Research Conference Call Participants Yaron Werber - Cowen Alex Thompson - Stifel Jim Birchenough - Wells Fargo Tyler Van Buren - Piper Sandler Vincent Chen - Bernstein Joel Beatty - Citi Yale Jen - Laidlaw ...

IONIS" Investor Day 2020 December 7, 2020 Forward Looking Language Statement This presentation includes forward-looking statements regarding our business, financial guidance and the therapeutic and commercial potential of SPINRAZA® (nusinersen), TEGSEDI® (inotersen), WAYLIVRA® (volanesorsen) and Ionis' technologies and products in development, including the business of Akcea Therapeutics, Inc., Ionis' wholly owned subsidiary. Any statement describing Ionis' goals, expectations, financial or other projection ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q3 2020 Earnings Conference Call November 4, 2020 11:30 AM ET Company Participants Wade Walke – Vice President of Investor Relations Brett Monia – Chief Executive Officer Beth Hougen – Chief Financial Officer Onaiza Cadoret – Chief Corporate Development and Commercial Officer Richard Geary – Executive Vice President of Development Eric Swayze – Executive Vice President of Research Kyle Jenne – Chief Commercial Officer-Akcea Conference Call Participants Do Kim – BMO ...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q2 2020 Earnings Conference Call August 5, 2020 11:30 AM ET Company Participants Wade Walke - Vice President of Investor Relations Brett Monia - Chief Executive Officer Beth Hougen - Chief Financial Officer Richard Geary - Executive Vice President of Development Onaiza Cadoret - Chief Corporate Development & Commercial Officer Conference Call Participants Jim Birchenough - Wells Fargo Ellie Merle - Cantor Fitzgerald Chad Messer - Needham & Company Tyler Van Buren - ...